Total Pageviews

Sunday, April 19, 2020

Dr. Fauci, the government bureaucrat, should have retired long ago

STAY  AT  HOME
LOCKDOWNS  
WERE  NEVER 
 "TESTED"
The stay at home 
orders were like a 
huge experimental 
treatment, with 
no control group, 
no evidence 
they would work, 
and obviously huge, 
and expected,
social and economic 
side effects, from the 
business shutdowns.

Stay at home orders, 
were issued by governors
in most states, and were
applied to most people
even though we knew
a very large percentage 
of Americans had no 
symptoms of COVID-19,
and young, healthy people
had a very low risk
of dying.

No one demanded
a double blind test
to prove the HUGE
stay at home decisions
were the right decisions !

We may never know.

The COVID-19 disease 
was spreading too fast
for hospitals to handle
in some European 
"hot spots", so we 
needed to "flatten 
the curve" in the U.S.

And hope the COVID-19 
spread would significantly
slow when the weather got
warmer and more humid,
like conventional flu strains. 

President Trump and 
his support staff, which
included Dr. Fauci,
have consistently 
received misleading 
and false information
from China.

When I heard about the 
mandatory lockdown
of Wuhan, i immediately
knew the epidemic was 
bad news, making the 
official Chinese death 
figures hard to believe.

Chinese communists
are notorious liars, so 
I had a good reason 
to not trust them. 

Truth is not a leftist
value, and China has 
a far left dictatorship. 

I did not know at the time
that many Wuhan residents
were allowed to "escape"
before the lockdown,
but not to other parts
of China, only out 
of the country,
I have heard !

If that's true, the Chinese
allowed their virus to 
attack the rest of the world.



HOW  HAS  DR. FAUCI
HELPED  AMERICANS ?
Dr. Fauci is the head 
of the National Institute 
of Allergy and Infectious 
Diseases ( NIAID ). 

So far this year he has
given President Trump
consistently bad advice.

I believe It is long 
past the time for 
Dr. Fauci to retire.

The Centers for 
Disease Control 
      ( CDC ) ,
and Fauci’s NIAID, 
are also shirking 
their immediate 
responsibility 
to compile the 
massive quantity of
field trial evidence 
-- a large number of 
2020 case-histories 
that can be turned into
a COVID-19 data set,
and analyzed.

CDC is 
supposed
to do that.

From the CDC’s
mission statement 
page:
"CDC in the 21st Century 
– confronting global disease threats 
through advanced computing 
and lab analysis of huge amounts 
of data to quickly find solutions."

But their 
official position, 
guided by the 
very visible Fauci, 
is that real-world data 
are not good enough.

Field experience 
( real world data 
from doctors ) 
reveals what 
treatments 
seem to work.

Clinical trials 
are used later,
to verify what 
doctors believe
to be working.

But bureaucrat Fauci 
doesn't want to analyze 
the real world data. 



In early 2020,
Dr. Fauci was telling
us COVID-19 was 
no big deal -- just 
keep on enjoying 
your life.

Go to the Super Bowl.

WRONG.

He convinced Trump
to be over optimistic
in early March, making
public statements 
that seem foolish now.

WRONG.

Then he convinced Trump
to be over pessimistic,
by late March, and we 
heard that two million
Americans could die,
according to one model.

WRONG.

In April 2020, Fauci 
was advising many
more months of 
the partial economic
shutdown -- forget 
about May 1, or June 1,
to reopen any businesses.

Probably wrong again.



Dr. Fauci is an 
elderly befuddled, 
long-term government 
bureaucrat, since the
Reagan Administration,
who gives the nation 
bad predictions, and 
bad advice.

His greatest faults
are quoting wild guess
models, dismissal of 
anecdotal evidence,
and the inability to 
say "I don't know".


For many weeks, 
Dr. Anthony Fauci 
dismissed all of
the evidence for
Hydroxychloroquine 
treatments for 
COVID-19, as 
“anecdotal” 
       and 
“the slightest hint 
of evidence” 
simply because 
the evidence
didn’t come from 
clinically controlled 
double blind tests.  

Wrong again. 

Valid statistics 
do need a 
control group.

But the control does 
not have to be a clinical
double blind test.

With a double blind test,  
doctors would have to 
withhold all medicines 
from half of their gravely 
ill patients, who would 
only get sugar pills.

That would be cruel 
when there is already 
a huge control group: 
  The thousands of 
case histories 
of COVID-19 patients 
all around the world, 
who never received 
Hydroxy treatments.

The outcomes 
from large samples 
of Hydroxy patients 
          versus
no Hydroxy patients,
needs to be compiled
quickly, and studied.

Any difference 
in patient mortality 
rates would be useful 
anecdotal data for
Hydroxychloroquine, 
because there are 
a very large number
of doctors and patients
trying that drug.

But old Dr. Fauci 
could not care less 
-- he has no plans 
to look at this huge 
body of field data. 

He plans to wait until 
clinically controlled 
double blind tests
are completed
this summer. 

Fauci said on April 9th:
"It’ll probably be months, 
sometime in the summer
—we’ll start to see 
which are working, 
which are not ,
and to focus on 
those that we 
are developing 
and will work".


But drug trials 
that use non-clinical 
controls are exactly 
what a younger 
Dr. Fauci used to
become famous !

Dr. Fauci's 
career-making 
medical research
was entirely 
dependent on 
historic controls 
( comparing
his treatment 
outcomes 
to historical 
mortality rates ),
with no clinical 
control groups 
ever involved.

Doctor Wolff 
and Dr. Fauci 
got famous for
treating Wegner’s 
Granulomatosis. 

They developed 
a treatment for it 
in the 70s and 80s 
that saved lives. 

Their "test" was not 
a random sample,
and NOT a controlled
double blind test.



We should be using 
the data we have NOW
for COVID-19.

There's lots of experience 
treating patients with
a combination of 
Hydroxychloroquine 
and Azithromycin.

Those are observational 
data, but still very useful.



Fauci’s own medical 
research was full of 
non-clinical controls.

His use of historical 
observational data 
was sound science. 

But now Fauci 
is against that 
for COVID-19.

Also, why is 
no one collecting
data on COVID-19 
outcomes for people
with arthritis, and/or 
lupus, who have been 
on hydroxychloroquine 
for years ?
  


Fauci is not withholding 
hydroxychlorquine.  

Doctors can prescribe it 
for COVID-19.

But Fauci has been 
discouraging its use 
for no logical reason.
       
Hydroxychloroquine
is not likely to ever get
an expensive clinical trial, 
because it is off-patent. 

Anyone can make it, 
and sell it as a generic,
so there's no profit motive
to fund clinical trials.

Double blind tests
are the gold standard, 
but drugs have been 
approved using 
alternative study 
designs, usually for life 
threatening conditions. 

COVID-19 is certainly
a life threatening condition,
and hydroxychloroquine
has had a low risk profile
over many decades.

No drugs are risk free.

Even aspirin.

In France, a combination 
of antimalarial drugs
and azithromycin, 
showed 43 cases of 
heart incidents linked to 
hydroxychloroquine.

A small study in Brazil 
had to be cut short after 
patients taking high-doses 
of chloroquine, to treat their 
COVID-19 symptoms, 
started to develop 
heart arrhythmias.



If you are looking for 
a small difference
between two drugs
for the same disease,
a controlled 
double blind trial 
makes sense.

You can ensure 
that every patient 
receives nearly 
identical care. 

In an environment 
that is not controlled, 
a very large sample size 
significantly reduces 
the margin of error.



The medical profession 
needs to move away 
from its fascination 
with randomized, 
controlled double
blind tests.

Generally, 
a new drug
needs two positive 
double blind tests 
that show it 
works better than 
a sugar pill, 
for FDA approval.

A new pain killer 
can be FDA approved 
even if it works
no better than aspirin.


When dealing with 
epidemics, where 
people are dying,
there's NOT enough time 
available for conducting
controlled double blind
tests.

Dr. Fauci does not care.

A large volume of COVID-19
patients can be analyzed, 
using “large data” methods, 
to determine the value of 
treatment alternatives, 
long before double blind
clinical trials can be 
completed.